residual c-peptide
Showing 1 - 25 of >10,000
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States
Recruiting
- Breast Adenocarcinoma
- +7 more
- Multi-epitope HER2 Peptide Vaccine TPIV100
- +5 more
-
Scottsdale, Arizona
- +26 more
Aug 17, 2022
MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)
Recruiting
- Myelodysplastic Syndromes
- DEC-C
- MyeloSeq-HD
-
Saint Louis, MissouriWashington University School of Medicine
Jan 18, 2023
Phantom Limb Pain, Neuroma Amputation Trial in Salt Lake City (Cooled Radiofrequency Ablation)
Active, not recruiting
- Phantom Limb Pain
- Neuroma Amputation
- Cooled Radiofrequency Ablation
-
Salt Lake City, UtahUniversity of Utah
Dec 3, 2022
Carotid Atherosclerosis Trial in Saint Louis (Cu[64]-25%-CANF-Comb PET-MR)
Completed
- Carotid Atherosclerosis
- Cu[64]-25%-CANF-Comb PET-MR
-
Saint Louis, MissouriWashington University in St.Louis
Oct 13, 2022
Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)
Recruiting
- Liver Cirrhosis
- +2 more
- Prolonged-Release Pirfenidone
-
Guadalajara, Jalisco, Mexico
- +1 more
Sep 13, 2022
Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease, Elderly Patients Trial in Beijing (colchicine)
Not yet recruiting
- Percutaneous Coronary Intervention
- +3 more
-
Beijing, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, CAM
Sep 1, 2023
Colon Cancer, Resected Stage Trial in Houston (Cetuximab, CB-NK-TGF-βR2-/NR3C1, Fludarabine phosphate)
Recruiting
- Colon Cancer
- Resected Stage
- Cetuximab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 23, 2022
Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)
Recruiting
- Migraine
- +3 more
- Click Digital Therapeutic
-
New York, New YorkClick Therapeutics
Aug 15, 2023
Basal Cell Carcinoma Trial in Miami (Optical Coherence Tomography (OCT), Curettage & Desiccation (C&D) Procedure)
Not yet recruiting
- Basal Cell Carcinoma
- Optical Coherence Tomography (OCT)
- Curettage & Desiccation (C&D) Procedure
-
Miami, FloridaUniversity of Miami
Apr 26, 2022
CANF-Comb-II PET-MR in Atherosclerosis Multisite
Recruiting
- Carotid Atherosclerosis
- +2 more
-
Los Angeles, California
- +1 more
Apr 27, 2023
Polycystic Ovary Syndrome, c Type Natriuretic Peptide, Menstrual Irregularity Trial in Nicosia (C type natriuretic peptide)
Completed
- Polycystic Ovary Syndrome
- +3 more
- C type natriuretic peptide
-
Nicosia, CyprusNear East University Faculty of Medicine
Oct 7, 2021
Development ofNovel Method to Measure Insulin Sensitivity in
Completed
- Insulin Sensitivity
- 24h Continuous glucose monitoring and urinary C-peptide collection
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jun 12, 2022
Clinical Performance Evaluation of the C2i Test
Not yet recruiting
- Muscle Invasive Bladder Cancer
- C2i-WGS-MRD Test
- (no location specified)
May 5, 2023
Hiv Trial in Philadelphia (Autologous CD4 T-Cells)
Completed
- Hiv
- Autologous CD4 T-Cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 13, 2022
Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Abrocitinib 200 MG Oral Tablet
- +2 more
- (no location specified)
Feb 21, 2023
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction
Not yet recruiting
- Non-small Cell Lung Cancer
- NGS and ctDNA-MRD detection
-
Changsha, Hunan, ChinaDepartment of Thoracic Surgery, Second Xiangya Hospital of Centr
Apr 18, 2023
Post Concussive Symptoms Trial (Early intervention programme, Enhanced usual care)
Active, not recruiting
- Post Concussive Symptoms
- Early intervention programme
- Enhanced usual care
- (no location specified)
Apr 11, 2023
Development of Predictive Biomarkers
Completed
- Type1diabetes
- Mixed Meal Tolerance Test
-
Milwaukee, WisconsinMedical College of Wisconsin
Nov 28, 2021
Healthy Trial (Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide, Peptide complexed HA Age Defying Gel with
Not yet recruiting
- Healthy
- Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide
- +4 more
- (no location specified)
Dec 11, 2022
Patients With Colorectal Cancer, the MiRDA-C Study
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Biospecimen Collection
- Electronic Health Record Review
-
Gilbert, Arizona
- +8 more
Aug 16, 2022
Breast Cancer Trial in United States (Placebo, GLSI-100)
Recruiting
- Breast Cancer
- Placebo
- GLSI-100
-
Birmingham, Alabama
- +21 more
Jan 30, 2023
Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)
Completed
- Alcohol Use Disorder
- [C-11]
- NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh PET Facility
Jul 8, 2022